Second-line and third-line therapy with nanoliposomal irinotecan (nal-IRI) in pancreatic cancer: a single-center experience and review of literature
纳米脂质体伊立替康（nal-IRI）在胰腺癌二线和三线治疗中的应用：单中心经验及文献综述
期刊:Journal of Gastrointestinal Oncology
影响因子:2
doi:10.21037/jgo-22-632
Möhring, Christian; Frontado Graffe, Freddy José; Bartels, Alexandra; Sadeghlar, Farsaneh; Zhou, Taotao; Mahn, Robert; Marinova, Milka; Feldmann, Georg; Brossart, Peter; Glowka, Tim R; Kalff, Jörg C; Strassburg, Christian P; Gonzalez-Carmona, Maria A
